- 201-500 Employees
- Based in Madrid, Spain
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, rest of Europe, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue…More sarcomas and for ovarian cancer; and Aplidin for treating multiple myeloma. The company also develops clinical-stage programs, including Lurbinectedin, PM184, and PM14. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain.
REPORT RATINGS4.7 / 5.0 (79)
PharmaMar reports have an aggregate usefulness score of 4.7 based on 79 reviews.
Most Recent Responsibility Report
2017 Corporate Social Responsibility Report
Report Locked. PharmaMar has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived PharmaMar Sustainability Report, PharmaMar Corporate Social Responsibility Report, PharmaMar CSR Report, PharmaMar Corporate Responsibility, PharmaMar CR Report, PharmaMar Citizenship Report, PharmaMar ESG Report, and PharmaMar Environmental Report online.